TransMedics (TMDX) Share-based Compensation (2018 - 2026)

TransMedics' Share-based Compensation history runs 9 years deep, the most recent figure standing at $10.0 million for Q1 2026.

• On a quarterly basis, Share-based Compensation rose 11.1% year-over-year to $10.0 million in Q1 2026; TTM through Mar 2026 was $19.6 million, a 20.28% decrease from a year earlier, with the FY2025 full-year figure at $63.1 million, up 15.57% from the prior year.
• Share-based Compensation improved to $10.0 million in Q1 2026 per TMDX's latest filing, from $657000.0 in the prior quarter.
• Across five years, Share-based Compensation topped out at $75.9 million in Q2 2025 and bottomed at -$11.9 million in Q4 2023.
• The 5-year median for Share-based Compensation is $5.1 million (2023), against an average of $12.4 million.
• Across the five-year window, Share-based Compensation tumbled 497.73% in 2023 and surged 893.07% in 2025, its largest moves.
• Year by year, Share-based Compensation stood at $3.0 million in 2022, then tumbled by 497.73% to -$11.9 million in 2023, then jumped by 166.78% to $7.9 million in 2024, then slumped by 91.73% to $657000.0 in 2025, then soared by 1414.76% to $10.0 million in 2026.
• Per Business Quant, the three latest TMDX Share-based Compensation figures stand at $10.0 million (Q1 2026), $657000.0 (Q4 2025), and $67.5 million (Q3 2025).